Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xian-yu Sun, Chun-yan Zhong, Qing-qing Qiu, Zhen-wang Li, Mei-yu Liu, Xin Wang & Cheng-hao Jin. (2019) Synthesis, activity evaluation, and pro-apoptotic properties of novel 1,2,4-triazol-3-amine derivatives as potent anti-lung cancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 1210-1217.
Read now
Read now
Articles from other publishers (22)
Ankush Kumar, Raj Kumar Narang & Rohit Bhatia. (2023) Recent advancements in NS5B inhibitors (2011-2021): Structural insights, SAR studies and clinical status. Journal of Molecular Structure 1293, pages 136272.
Crossref
Crossref
Ecem Gökoğlan, Damla Dere, İpek Bedir, Kemal Yelekçi, Dilek Telci & Ş. Güniz Küçükgüzel. (2023) Synthesis and investigation of cytotoxic effects of compounds derived from flurbiprofen. Journal of Molecular Structure 1289, pages 135876.
Crossref
Crossref
Roberta Bivacqua, Marilia Barreca, Virginia Spanò, Maria Valeria Raimondi, Isabella Romeo, Stefano Alcaro, Graciela Andrei, Paola Barraja & Alessandra Montalbano. (2023) Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors. European Journal of Medicinal Chemistry 249, pages 115136.
Crossref
Crossref
Göknil COŞKUN, Kaan BİRGÜL, Asaf Evrim EVREN, Ş.güniz KÜÇÜKGÜZEL & Mert ÜLGEN. (2023) In silico studies and in vitro microsomal metabolism of potent MetAP2 inhibitor and in vivo tumor suppressor for prostate cancer: A thioether-triazole hybrid. Acibadem Universitesi Saglik Bilimleri Dergisi 14:1.
Crossref
Crossref
Gizem Erensoy, Kai Ding, Chang-Guo Zhan, Gamze Çiftçi, Kemal Yelekçi, Merve Duracık, Özlem Bingöl Özakpınar, Esra Aydemir, Zübeyde Nur Yılmaz, Fikrettin Şahin, Necla Kulabaş, Esra Tatar & İlkay Küçükgüzel. (2023) Synthesis, in vitro and in silico studies on novel 3-aryloxymethyl-5-[(2-oxo-2-arylethyl)sulfanyl]-1,2,4-triazoles and their oxime derivatives as potent inhibitors of mPGES-1. Journal of Molecular Structure 1272, pages 134154.
Crossref
Crossref
Ferah Comert Onder, Pinar Siyah, Serdar Durdagi, Mehmet Ay & Bulent Ozpolat. (2022) Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy. RSC Medicinal Chemistry 13:7, pages 840-849.
Crossref
Crossref
Kaan Birgül, Abdullah Ibrahim Uba, Ozan Çuhadar, Sevgi Koçyiğit Sevinç, Selen Tiryaki, Pınar Mega Tiber, Oya Orun, Dilek Telci, Özgür Yılmaz, Kemal Yelekçi & Ş. Güniz Küçükgüzel. (2022) Synthesis and molecular modeling of MetAP2 of thiosemicarbazides, 1,2,4-triazoles, thioethers derived from (S)-Naproxen as possible breast cancer agents. Journal of Molecular Structure 1259, pages 132739.
Crossref
Crossref
M.İhsan Han, Cansu Ümran Tunç, Pınar Atalay, Ömer Erdoğan, Gökhan Ünal, Mehmet Bozkurt, Ömer Aydın, Özge Çevik & Ş. Güniz Küçükgüzel. (2022)
Design, synthesis, and
in vitro
and
in vivo
anticancer activity studies of new (
S
)-Naproxen thiosemicarbazide/1,2,4-triazole derivatives
. New Journal of Chemistry 46:13, pages 6046-6059.
Crossref
Crossref
Han Zhang, Xin Zheng, Jichong Li, Qingbo Liu, Xiao-Xiao Huang, Huaiwei Ding, Ryosuke Suzuki, Masamichi Muramatsu & Shao-Jiang Song. (2021) Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: Synthesis and biological evaluation. European Journal of Medicinal Chemistry 218, pages 113395.
Crossref
Crossref
S. A. El‐Sebaey. (2020) Recent Advances in 1,2,4‐Triazole Scaffolds as Antiviral Agents. ChemistrySelect 5:37, pages 11654-11680.
Crossref
Crossref
Xiaoyue Wen, Yongqin Zhou, Junhao Zeng & Xinyue Liu. (2020) Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents. Current Topics in Medicinal Chemistry 20:16, pages 1441-1460.
Crossref
Crossref
Monika Pitucha, Monika Janeczko, Katarzyna Klimek, Emilia Fornal, Maciej Wos, Anna Pachuta-Stec, Grazyna Ginalska & Agnieszka A. Kaczor. (2020) 1,2,4-Triazolin-5-thione derivatives with anticancer activity as CK1γ kinase inhibitors. Bioorganic Chemistry 99, pages 103806.
Crossref
Crossref
Muhammed İ. Han, Hatice Bekçi, Abdullahi I. Uba, Yeliz Yıldırım, Ercüment Karasulu, Ahmet Cumaoğlu, Hatice Y. Karasulu, Kemal Yelekçi, Özgür Yılmaz & Ş. Güniz Küçükgüzel. (2019)
Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4‐triazole containing hydrazide–hydrazones derived from (
S
)‐naproxen
. Archiv der Pharmazie 352:6, pages 1800365.
Crossref
Crossref
Göknil Coşkun, Teodora Djikic, Taha Hayal, Nezaket Türkel, Kemal Yelekçi, Fikrettin Şahin & Ş. Küçükgüzel. (2018) Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors. Molecules 23:8, pages 1969.
Crossref
Crossref
Bhaskar Kummari, Perla Ramesh, Rayam Parsharamulu, Tejeswara Rao Allaka, Hasithashilpa Anantaraju, Perumal Yogeeswari, Sridhar Balasubramanian, Sravanthi Devi Guggilapu, Bathini Nagendra Babu & Jaya Shree Anireddy. (2018)
Design and Synthesis of New Etodolac‐Pyridazinones as Potent Anticancer Agents Using Pb(OAc)
4
to Assist N‐N Bond Formation
. ChemistrySelect 3:18, pages 5050-5054.
Crossref
Crossref
Işıl Çoruh, Özge Çevik, Kemal Yelekçi, Teodora Djikic & Ş. Güniz Küçükgüzel. (2018) Synthesis, anticancer activity, and molecular modeling of etodolac-thioether derivatives as potent methionine aminopeptidase (type II) inhibitors. Archiv der Pharmazie 351:3-4, pages 1700195.
Crossref
Crossref
Shilpa M. Somagond, Ravindra R. Kamble, Pramod P. Kattimani, Saba Kauser J. Shaikh, Sheshagiri R. Dixit, Shrinivas D. Joshi & Hirihalli C. Devarajegowda. (2018)
Design, Docking, and Synthesis of Quinoline‐2
H
‐1,2,4‐triazol‐3(4
H
)‐ones as Potent Anticancer and Antitubercular Agents
. ChemistrySelect 3:7, pages 2004-2016.
Crossref
Crossref
Mohammed M. Abadleh, Mustafa M. El-Abadelah & Monther S. Zreid. (2018) One-Pot Synthesis of Model 1H,1'H-5,5'-Bi(1,2,4-Triazoles). HETEROCYCLES 96:6, pages 1080.
Crossref
Crossref
Mahnaz Farahi, Bahador Karami, Zohreh Banaki, Fatemeh Rastgoo & Khalil Eskandari. (2017) TSA-catalyzed regioselective synthesis of medicinally important 4-aryl-substituted dihydropyrimidine derivatives fused to pyrazole and triazole scaffolds via an efficient and green Domino reaction. Monatshefte für Chemie - Chemical Monthly 148:8, pages 1469-1475.
Crossref
Crossref
Necla Kulabaş, Esra Tatar, Özlem Bingöl Özakpınar, Derya Özsavcı, Christophe Pannecouque, Erik De Clercq & İlkay Küçükgüzel. (2016) Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells. European Journal of Medicinal Chemistry 121, pages 58-70.
Crossref
Crossref
Sevil Şenkardeş, Neerja Kaushik-Basu, İrem Durmaz, Dinesh Manvar, Amartya Basu, Rengül Atalay & Ş. Güniz Küçükgüzel. (2016) Synthesis of novel diflunisal hydrazide–hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors. European Journal of Medicinal Chemistry 108, pages 301-308.
Crossref
Crossref
Ş.Güniz Küçükgüzel & Pelin Çıkla-Süzgün. (2015) Recent advances bioactive 1,2,4-triazole-3-thiones. European Journal of Medicinal Chemistry 97, pages 830-870.
Crossref
Crossref